Results 21 to 30 of about 71,753 (234)
Methadone for Opioid Use Treatment during Pregnancy: Trends in Postpartum Dose Adjustments
American Journal of Perinatology Reports, 2020 Objective This study examines methadone dose adjustment postpartum. Methods A retrospective study of women with methadone for opioid use treatment (OUT) during pregnancy was performed.
Clara Ward, Carl W. Christensen
doaj +1 more source
Health disparities in chronic liver disease
Hepatology, EarlyView., 2022 Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian +3 more
wiley +1 more source
Addiction Science & Clinical Practice, 2022 Background Residential treatment is a common approach for treating opioid use disorder (OUD), however, few studies have directly compared it to outpatient treatment.
Daniel M. Hartung +11 more
doaj +1 more source
SnapShot: Neurobiology of opioid use disorder [PDF]
Cell, 2021 The use of opioid drugs and related overdose deaths, which rose to epidemic proportions over the past decade, have been exacerbated by the COVID pandemic, a time of great uncertainty and isolation. Much is known about opioid pharmacology and related neural circuits that, combined with novel emerging neurobiological insights, can help guide new ...
Randall J, Ellis +3 more
openaire +2 more sources
Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
Drug and Alcohol Dependence Reports, 2022 Background: Patients with opioid use disorder (OUD) have high hospital admission rates. Hospitalists, clinicians that work in inpatient medical settings, may have a unique opportunity to intervene on behalf of these patients, yet their experience with ...
Megan K Reed +5 more
doaj +1 more source
Medication Treatment of Opioid Use Disorder [PDF]
Biological Psychiatry, 2020 Opioid use disorder (OUD) is a chronic, relapsing condition, often associated with legal, interpersonal, and employment problems. Medications demonstrated to be effective for OUD are methadone (a full opioid agonist), buprenorphine (a partial agonist), and naltrexone (an opioid antagonist).
James Bell, John Strang
openaire +4 more sources
Ibrain, EarlyView., 2023 This study compared the clinical effectiveness and treatment satisfaction of Pregabalin and Gabapentin triple therapy for neuropathic pain in a real‐world setting. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from baseline to 12 weeks posttreatment.
Nithya Raju +7 more
wiley +1 more source
Comorbid opioid use is undertreated among forensic patients with schizophrenia
Substance Abuse Treatment, Prevention, and Policy, 2018 Background Substance use disorders are associated with poorer clinical outcomes in patients with schizophrenia. There is no specific treatment for amphetamine or cannabis use disorder, but methadone and buprenorphine are used as replacement therapy in ...
Kristiina Kivimies +3 more
doaj +1 more source
COVID‐19: A new barrier to treatment for opioid use disorder in the emergency department
Journal of the American College of Emergency Physicians Open, 2021 Objective Start Treatment and Recover (STAR) is an emergency department (ED) program that expands access to medication for opioid use disorder by identifying patients with opioid use disorder and offering ED‐initiated buprenorphine/naloxone and rapid ...
Warren Grunvald +7 more
doaj +1 more source
Addiction Science & Clinical Practice, 2019 Background The study examined the association of the Affordable Care Act’s 2014 Medicaid expansion on the use of psychosocial services and pharmacotherapies for opioid use disorders among Oregon Medicaid recipients.
Dennis McCarty +3 more
doaj +1 more source